Regeneron, Teva take aim at Lilly/Pfizer pain drug
September 20, 2016 at 07:00 AM EDT
Sept 20 (Reuters) - Regeneron Pharmaceuticals Inc and Israeli drugmaker Teva Pharmaceutical Industries on Tuesday said they would co-develop Regeneron's experimental new type of pain drug and together market the medicine if it succeeds in trials and is approved.
